Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

Rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) promoted Erik Harris to EVP and chief commercial officer from SVP, head of North American commercial operations.

Bispecific antibody company F-star Biotechnology Ltd. (Cambridge, U.K.) said CFO Tolga Hassan will become COO. Darlene Deptula-Hicks will succeed Hassan as CFO. She was CFO of Northern Biologics Inc. (Toronto, Ont.)...